The global healthcare microfluidics market is expected to grow at a CAGR of 12.2% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for personalized medicine and rising prevalence of chronic diseases. The global healthcare microfluidics market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into glass based, polymer based, silicon based and others (metallic). On the basis of application, it is divided into homecare and hospitals. Geographically it covers North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- The increasing demand for point-of-care diagnostics and the need for faster, more accurate, and less expensive diagnostic tests are driving the growth of this market.
- The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is also driving the growth of this market.
- Increasing government funding in developing countries such as China and India is also driving the growth of this market.
- Increasing research activities in developing countries such as China and India are also driving the growth of this market.
Industry Growth Insights published a new data on “Healthcare Microfluidics Market”. The research report is titled “Healthcare Microfluidics Market research by Types (Glass Based, Polymer Based, Silicon Based, Others, ), By Applications (Homecare, Hospitals, Others, ), By Players/Companies Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche, IDEX Corporation, PerkinElmer, Thermo Fisher Scientific”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Healthcare Microfluidics Market Research Report
By Type
Glass Based, Polymer Based, Silicon Based, Others,
By Application
Homecare, Hospitals, Others,
By Companies
Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche, IDEX Corporation, PerkinElmer, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Healthcare Microfluidics Market Report Segments:
The global Healthcare Microfluidics market is segmented on the basis of:
Types
Glass Based, Polymer Based, Silicon Based, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Homecare, Hospitals, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Agilent Technologies, Inc.
- BD
- Bio-Rad Laboratories
- Danaher Corporation
- Roche
- IDEX Corporation
- PerkinElmer
- Thermo Fisher Scientific
Highlights of The Healthcare Microfluidics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glass Based
- Polymer Based
- Silicon Based
- Others
- By Application:
- Homecare
- Hospitals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Healthcare Microfluidics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microfluidics is a technology that uses small channels and droplets to control the movement of fluids. This technology can be used in many different areas of healthcare, including drug delivery, diagnostics, and treatment.
Some of the major players in the healthcare microfluidics market are Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche, IDEX Corporation, PerkinElmer, Thermo Fisher Scientific.
The healthcare microfluidics market is expected to grow at a compound annual growth rate of 12.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Healthcare Microfluidics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Healthcare Microfluidics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Healthcare Microfluidics Market - Supply Chain
4.5. Global Healthcare Microfluidics Market Forecast
4.5.1. Healthcare Microfluidics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Healthcare Microfluidics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Healthcare Microfluidics Market Absolute $ Opportunity
5. Global Healthcare Microfluidics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Healthcare Microfluidics Market Size and Volume Forecast by Type
5.3.1. Glass Based
5.3.2. Polymer Based
5.3.3. Silicon Based
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Healthcare Microfluidics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Healthcare Microfluidics Market Size and Volume Forecast by Application
6.3.1. Homecare
6.3.2. Hospitals
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Healthcare Microfluidics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Healthcare Microfluidics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Healthcare Microfluidics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Healthcare Microfluidics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Healthcare Microfluidics Demand Share Forecast, 2019-2026
9. North America Healthcare Microfluidics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Healthcare Microfluidics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Healthcare Microfluidics Market Size and Volume Forecast by Application
9.4.1. Homecare
9.4.2. Hospitals
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Healthcare Microfluidics Market Size and Volume Forecast by Type
9.7.1. Glass Based
9.7.2. Polymer Based
9.7.3. Silicon Based
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Healthcare Microfluidics Demand Share Forecast, 2019-2026
10. Latin America Healthcare Microfluidics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Healthcare Microfluidics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Healthcare Microfluidics Market Size and Volume Forecast by Application
10.4.1. Homecare
10.4.2. Hospitals
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Healthcare Microfluidics Market Size and Volume Forecast by Type
10.7.1. Glass Based
10.7.2. Polymer Based
10.7.3. Silicon Based
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Healthcare Microfluidics Demand Share Forecast, 2019-2026
11. Europe Healthcare Microfluidics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Healthcare Microfluidics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Healthcare Microfluidics Market Size and Volume Forecast by Application
11.4.1. Homecare
11.4.2. Hospitals
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Healthcare Microfluidics Market Size and Volume Forecast by Type
11.7.1. Glass Based
11.7.2. Polymer Based
11.7.3. Silicon Based
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Healthcare Microfluidics Demand Share, 2019-2026
12. Asia Pacific Healthcare Microfluidics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Healthcare Microfluidics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Healthcare Microfluidics Market Size and Volume Forecast by Application
12.4.1. Homecare
12.4.2. Hospitals
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Healthcare Microfluidics Market Size and Volume Forecast by Type
12.7.1. Glass Based
12.7.2. Polymer Based
12.7.3. Silicon Based
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Healthcare Microfluidics Demand Share, 2019-2026
13. Middle East & Africa Healthcare Microfluidics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Healthcare Microfluidics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Healthcare Microfluidics Market Size and Volume Forecast by Application
13.4.1. Homecare
13.4.2. Hospitals
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Healthcare Microfluidics Market Size and Volume Forecast by Type
13.7.1. Glass Based
13.7.2. Polymer Based
13.7.3. Silicon Based
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Healthcare Microfluidics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Healthcare Microfluidics Market: Market Share Analysis
14.2. Healthcare Microfluidics Distributors and Customers
14.3. Healthcare Microfluidics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent Technologies, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bio-Rad Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Danaher Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Roche
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. IDEX Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. PerkinElmer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Fisher Scientific
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook